Use of nebulized antimicrobial agents in burned and mechanically ventilated patients with persistent Acinetobacter baumannii, Pseudomonas aeruginosa, or Enterobacteriacea

Burns

Volumn 39, Issue 5, 2013, Pages 885-891

  Ackerman, Bruce H ^a   Reigart, Cynthia L ^a   Stair Buchmann, Megan ^a   Haith Jr , Linwood R ^a   Patton, Mary L ^a   Guilday, Robert E ^a  

^a CROZER CHESTER MEDICAL CENTER   (United States)

Author keywords

Alternative antibiotic therapy with resistant organisms; Nebulization therapy for prolong ventilatory dependent patients; Ventilator dependent patient antibiotic nebulizations

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMPHOTERICIN B; ANTIBIOTIC AGENT; COLISTIMETHATE; CREATININE; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACUTE DISEASE; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BURN; BURN PATIENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EXPOSURE; DRUG INDUCED DISEASE; HUMAN; INTERACTIVE VENTILATORY SUPPORT; KIDNEY DISEASE; KLEBSIELLA; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MYCOSIS; NEBULIZATION; NEBULIZER; NEPHROTOXICITY; NONHUMAN; PNEUMONIA; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SIDE EFFECT; SYSTEMIC THERAPY; TRACHEOBRONCHITIS; TREATMENT DURATION; VENTILATED PATIENT; ACINETOBACTER INFECTIONS; ANALYSIS OF VARIANCE; COMPLICATION; ENTEROBACTERIACEAE INFECTIONS; FEMALE; INHALATIONAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; LUNG BURN; MALE; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PSEUDOMONAS INFECTIONS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADMINISTRATION, INHALATION; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BURNS; BURNS, INHALATION; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PNEUMONIA, VENTILATOR-ASSOCIATED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES;

EID: 84879008967     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2012.10.026     Document Type: Article

References (32)

1. G.C. Wood, and B.A. Boucher Aerosolized antimicrobial therapy in acutely ill patients Pharmacotherapy 20 2000 166 181
2. J. Klastersky, C. Geuning, E. Mouawad, and D. Daneau Endotracheal gentamicin in bronchial infections in patients with tracheostomy Chest 61 1972 172 220
3. D. Warren Endotracheally administered aminoglycosides for Gram-negative bronchopneumonias Hosp Pharm 15 1980 322 323
4. J. Klastersky, C. Hensgens, J. Noterman, E. Mouawad, and F. Meunier-Carpentier Endotracheal antibiotics for the prevention of tracheobronchial infections in tracheotomized unconscious patients. A comparative study of gentamicin and aminosidin-polymyxin B combination Chest 68 1975 302 306
5. R.B. Brown, J.A. Kruse, G.W. Counts, J.A. Russell, N.V. Christou, and M.L. Sands Double-blind study of endotracheal tobramycin in the treatment of Gram-negative bacterial pneumonia Antimicrob Agents Chemother 34 1990 269 272
6. G. Mombelli, L. Coppens, J.P. Thys, and J. Klastersky Antipseudomonal activity in bronchial secretions of patients receiving amikacin or tobramycin as a continuous infusion Antimicrob Agents Chemother 19 1981 72 75
7. J. Klastersky, F. Carpentier-Meunier, L. Kahan-Coppens, and J.P. Thys Endotracheally administered antibiotics for Gram-negative pneumonia Chest 75 1979 586 591
8. L.B. Palmer, G.C. Smaldone, J.J. Chen, D. Baram, T. Duan, and M. Montefort Aerosolized antibiotics in mechanically ventilated patients: delivery and response Crit Care Med 26 1998 31 39
9. J. Klastersky, E. Huysmans, D. Weerts, C. Hensgens, and D. Daneau Endotracheally administered gentamicin for prevention of infection of the respiratory tract in patients with tracheostomy: a double blind study Chest 65 1974 650 654
10. J. Rathgeber, S. Zielmann, C. Panzer, and H. Burchardi Prevention of pneumonia by endotracheal micronebulization of tobramycin (abstract) Anaesthesiol Intensivemed Notfallmed Schmerzther 28 1993 23 29
11. M.E. Falagas, and S.K. Kasiakou Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis Infection 35 2007 3 10
12. M.L. Sole, F.E. Poalillo, J.F. Byers, and J.E. Ludy Bacterial growth in secretions and on suctioning equipment of orally intubated patients: a pilot study Am J Crit Care 11 2002 141 149
13. S.S. Crosby, W.A.D. Edwards, C. Brennan, D.P. Dellinger, and L.A. Bauer Systemic absorption of endotracheally administered aminoglycosides in seriously ill patients with pneumonia Antimicrob Agents Chemother 31 1987 850 853
14. American Thoracic Society, and Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 2005 388 416
15. M.A. Ashlock, R.J. Beall, N.M. Hamblett, M.W. Konstan, C.M. Penland, and B.W. Ramsey A pipeline of therapies for cystic fibrosis Semin Resp Crit Care Med 30 2009 611 626
16. P.A. LoBue [editorial] Inhaled tobramycin: not just for cystic fibrosis anymore? Chest 127 2005 1098 1100
17. W.A. Krueger, and K.E. Unertl Selective decontamination of the digestive tract Curr Opin Crit Care 8 2002 139 144
18. A. Liberati, R. D'Amico, S. Pifferi, V. Torri, L. Brazzi, and E. Parmelli Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care Issue 4 2009 The Cochrane Collaboration, the Cochrane Library p. 1-74
19. M.A. de La Cal, E. Cerda, P. Garcia-Hierro, H.K. van Saene, D. Gommez-Santos, and J.A. Lorente Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial Ann Surg 241 2005 424 430
20. M.J.M. Bonten Strategies for prevention of hospital-acquired pneumonia: oral and selective decontamination of the gastrointestinal tract Semin Resp Crit Care Med 23 2002 481 488
21. N.M. Doshi, K.L. Mount, and C.V. Murphy Nephrotoxicity associated with intravenous colistin in critically ill patients Pharmacotherapy 31 2011 1257 1264
22. H.D. Spapen, P.M. Honore, N. Gregoire, P. Gobin, J. de Regt, and G.A. Martens Convulsions and apnoea in a patient infected with New Delhi metallo-beta-lactamase-1 Escherichia coli treated with colistin J Infect 63 2011 468 470
23. H. Ko, M. Jeon, E. Choo, E. Lee, T. Kim, and J.B. Jun Early acute kidney injury is a risk factor that predicts mortality in patients treated with colistin Nephron 117 2011 c284 c288
24. K. Wahby, T. Chopra, and P. Chandrasekar Intravenous and inhalational colistin-induced respiratory failure Clin Infect Dis 50 2010 e38 e40
25. S.J. Pacella, D. Harkins, D. Butz, W.M. Kuzon Jr., and P.A. Taheri Referral patterns and severity distribution of burn care: implications for burn centers and surgical training Ann Plastic Surg 54 2005 412 419
26. C.R. Smith, R.D. Moore, and P.S. Lietman Studies of risk factors for aminoglycoside nephrotoxicity Am J Kidney Dis 8 1986 308 313
27. Centers for Disease Control and Prevention. Pneumonia guidelines. www.unc.edu/depts/spice/pneumonia.doc, 2008.
28. J. Le, E.D. Ashley, M.M. Neumhauser, J. Brown, C. Gentry, and M.E. Klepser Consensus summary of aerosolized antimicrobial agents: application of guideline criteria - insights from the Society of Infectious Diseases Pharmacists Pharmacotherapy 30 2010 562 584
29. C.-E. Luyt, A. Combes, A. Niezowska, J.-L. Trouillet, and J. Chastre Aerosolized antibiotics to treat ventilator-associated pneumonia Curr Opin Infect Dis 22 2009 154 158
30. T. Osler, L. Glance, and D.W. Hosmer Simplified estimates of the probability of death after burn injuries: extending and updating the Baux score J Trauma 68 2010 690 697
31. M. Eveillard, C. Soltner, M. Kempf, J.-P. Saint-André, C. Lemarie, and C. Randrianarivelo The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia J Infect 60 2010 154 161
32. A.C. Weintrob, M.P. Roediger, M. Barber, A. Summers, A.M. Fieberg, and J. Dunn Natural history of colonization with Gram-negative multidrug-resistant organism among hospitalized patients Infect Control Hosp Epidem 31 2010 330 337